Search Results

GPCR Enthusiasts , Get ready for an exciting learning experience with our newly updated Principles of Pharmacology New Course Dates: Principles of Pharmacology I :  October 3, 10, 17, 24 (four sessions) Principles Fast: Don’t miss this incredible opportunity to immerse yourself in the  Principles of Pharmacology and ' Advanced Data Analysis for GPCR Pharmacology' ." GLP-1 drugs’ Opening Ceremony of Xuzhou Zhongshu Research Site and CNS Drug Innovation Forum Nxera Pharma

Breakthroughs this week:  Potentiation of GPCR signaling by ATP and sugar monophosphates; Pharmacology 2025; Nxera Pharma earns $10m milestone from AbbVie neurological deal. 🔍 This Week in Dr. Kenakin — October 30, 12 PM EST Bring your toughest pharmacology questions and join Dr. Kenakin Trusted insights across biotech, pharma, and academia 💎 $2,999/year — one conference cost = GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Recognizing, predicting, and leveraging these interactions is the essence of enzyme inhibition pharmacology Clark , laid the foundation for today’s quantitative pharmacology. Enzyme Inhibition Pharmacology: Orthosteric vs. Kenakin Content trusted by biotech, pharma, and academia 💎 $2999/year — one conference cost = a full Pharmacology isn’t just about hitting the receptor—it’s about surviving the enzymes first.

Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein Nxera Pharma and Antiverse partner on GPCRs Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial with ORX750, | BIO International Convention 2025 July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology Principal Scientist, Medicinal Chemistry PhD fellowship in GPCR mechanosensing Senior Scientist, GPCR Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group

Pharma interest is high, as reflected in major deals across the space. GPCR-Targeted Drug Discovery Summit 2026 The meeting brings together 80+ senior leaders from biotech and pharma discovery through translation — experts in GPCR biology, structural biology, computational design, pharmacology Therapeutics  ·  Confo Therapeutics  ·  Eli Lilly  ·  GSK  ·  Nabla Bio  ·  Northeastern University  ·  Nxera Pharma

Over the years, we’ve built a global network of researchers, biotech leaders, and pharma innovators who Push the boundaries  of receptor pharmacology and its real-world applications.   📚 Terry’s Corner — The Only On-Demand Pharmacology Hub with Dr. GPCR  community, you already know about Terry’s Corner  — our exclusive, on-demand pharmacology series where Terry Kenakin breaks down receptor pharmacology, functional selectivity, and ligand bias in a

exactly what Terry’s Corner delivers this week: high-impact insight into GPCR allostery, crafted for pharmacologists Career opportunities:  Exclusive pharma and academic listings you won’t find on job boards—curated for Exploit probe dependence to shape precision pharmacology.  Want to avoid off-target effects? If you work on GPCRs across translational pharmacology, drug development, or molecular pharmacology, GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

For decades, GPCRs have been the cornerstone of pharmacology. Projects in his group often begin with either: A new GPCR structure  ripe for exploration, or A pharmacological Carlsson’s group integrates modeling with mechanistic pharmacology. for Drug Discovery While the Carlsson lab is rooted in academia, its impact extends into biotech and pharma improved GPCR structures, and scalable experimental assays is shrinking the gap between modeling and pharmacology

Kenakin’s latest lecture delivers a wake-up call for pharmacologists interpreting allosteric binding Function: Two Different Worlds One of the most common—and dangerous—mistakes in allosteric pharmacology When a PAM increases radioligand binding but suppresses functional response, it’s not broken pharmacology—it The takeaway:  what looks like pharmacology failure may be a systems problem . Terry Kenakin An always-growing library of on-demand pharmacology insights The ability to vote on or

How do competing ligands slow or alter binding rates, and what does this tell you about real-world pharmacology candidates faster Unlock “Drug Binding Kinetics” Now Only in Terry’s Corner   ______ #DrugDiscovery #Pharmacology #DrugKinetics #PipelineEfficiency #PharmaInnovation #GPCR #BindingKinetics #MedicinalChemistry #LeadOptimization

Career opportunities:  Principal Scientist - In Vitro Pharmacology; Senior Scientist, Molecular Pharmacology Weekly News : jobs, events, papers, industry updates Exclusive discounts on Terry’s Corner  digital pharmacology access to insights from major conferences, emerging research, and expert commentary Whether you’re a pharmacologist GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who Edition here ➤    Access all the news and upcoming events Hashtags: #GPCR #DrGPCR #BindingAffinity #Pharmacology

Rethinking Affinity, A Critical Edge for Drug Hunters One of the most persistent misconceptions in pharmacology Katerina Leftheris : New technologies overcoming peptide limitations with insights from both pharma and At Alkermes, Sokhom Pin built an in vitro pharmacology group from scratch—not just a lab, but a culture Scientists, drug discovery teams, and pharmacologists who need curated, career-relevant updates. Access this week’s full Premium Edition here ➤ Hashtags: #GPCR #DrGPCR #BindingAffinity #Pharmacology

Every R&D team is under the same pressure: deliver validated targets, clean pharmacology, and translatable Allosteric Interactions Still Matter Orthosteric and allosteric interactions have been in pharmacology learn why this distinction is not just theory, but a practical framework to design cleaner, smarter pharmacology Equip your team with this literacy now to design cleaner pharmacology and accelerate smarter, safer programs topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built for biotech, pharma

Tomas , Kyle Sloop , et al. for their outstanding study on Class B1 GPCRs: insights into multireceptor pharmacology ’s dive into the   Classified GPCR News from October 28th to November 3rd, 2024 Industry News Nxera Pharma Third Quarter and First Nine Months of 2024 Nasdaq debutante Septerna swells its IPO to $331m Nxera Pharma Drug Discovery NEW March 12 - 14, 2025 | NextGen Biomed 2025 NEW March 25 - 28, 2025 | 10th German Pharm-Tox Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group

Each week we highlight the decisions that move GPCR projects forward—from pharmacology essentials to topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built for biotech, pharma Years of chemistry, photophysics, and pharmacology condensed into one breakthrough: pHSense , a reagent They translated a fundamental principle of chemistry into a usable platform for pharmacology—showing GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Who should come This evening is open to pharma, biotech, academia, and students. This event is open to pharma, biotech, academia, and students.

But Sokhom Pin stayed loyal to GPCRs , even when big pharma turned its gaze to other targets like kinases refining assays, exploring signaling bias, and building a robust knowledge base in one of the most pharmacologically

Whether supporting CROs, academic labs, or pharma teams, Celtarys engages deeply with collaborators to

Our mission is simple: bridge science and industry  by connecting researchers, biotech, CROs, and pharma Since 2007, NIS   has been a trailblazing CRO making cryo-electron microscopy (cryo-EM) accessible to pharma

October 2022 Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment The network pharmacology method was used to constructe the "herb-component-target" network, and elucidated

This study demonstrated the pharmacological properties and functions of PxOctβ3 in P. xylostella, thus

2026 GPCR Pharmacology AMA: Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology The objective is straightforward: Make mechanistic pharmacology easier to access, revisit, and apply Access the white paper here Why Terry’s Pharmacology Corner Mechanistic understanding evolves. Pharmacology does not drift because data are missing. It drifts when interpretation becomes casual. Terry’s Pharmacology Corner provides a structured environment to maintain interpretive discipline: Weekly

Previous pharmacophore modeling studies of the β3 -AR did not involve experimental in vitro validation Ligand-based pharmacophore modeling was performed since no 3D structure of human β3 -AR is yet available A dataset consisting of β3 -AR agonists was prepared to build and validate the pharmacophore models.

Teams equipped with deep GPCR pharmacology insights make different decisions. The sections below synthesize the key topics addressed during the AMA and highlight the GPCR pharmacology Physiological Feedback Reshapes Pharmacology The dobutamine example resurfaced for a reason. This is a core GPCR pharmacology insight:ligand → receptor → G protein is never the entire story. Kenakin  emphasized that the key advantage is not subtlety for its own sake—it’s bounded pharmacology

When the story isn’t evolving, they assume the company isn’t either. 2️⃣ BD Momentum Flatlines Pharma source of truth for timelines and decisions It looks good: No one, from intern to CSO, board member, or pharma

Highlights: Congratulations to our amazing Board Member JoAnn Trejo for being elected to the British Pharmacological News from December 2nd to 8th, 2024 Industry News 2024 Fellows and Honorary Fellows announced Nxera Pharma to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28, 2025 | 10th German Pharm-Tox GPCR Jobs GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group

Terry's Corner - New Course on Pharmacologic Models The latest Terry’s Corner unlocks clinical forecasting in the full newsletter   Secure Your Access Now ➤ 🗣️ “Thank you for bringing this (Principles of Pharmacology

April 2022 Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization --Design Pharmaceuticals, a company redesigning small molecule drug discovery, today announced the closing Design Pharmaceuticals’ platform is based on ultrahigh-throughput technologies that biomine drug-like

April 2022 "SAN DIEGO, April 12, 2022 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization

April 2022 Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders Addex Therapeutics "Tim Dyer is the Co-Founder and CEO of Addex Therapeutics, which is focusing on the pharmacology